EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Identification and External Transcriptomic Validation of a B Cell-Associated Prognostic Genes in Cutaneous Melanoma

Junshen Wu, Maierdanjiang Maihemuti, Wenpeng Yang, Haiyang He, Renbing Jiang

Clinical, Cosmetic and Investigational Dermatology · 2026-11 · Volume 19 · 1-21

DOI: 10.2147/ccid.s637618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-11. Verfasst von Junshen Wu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

B cells play a crucial role in skin cutaneous melanoma (SKCM) and other cancers, but their specific mechanisms remain unclear.

Methods

This study utilized SKCM-related datasets (GSE15605, TCGA-SKCM, and GSE65904) along with B cell-related genes (BRGs). Candidate genes were accurately identified by intersecting the differentially expressed genes (DEGs) and key module genes. In the TCGA-SKCM dataset, univariate Cox regression and LASSO regression were performed to screen prognostic genes, which were further selected to construct the risk model. SKCM patients were clearly stratified into high and low cohorts using this model, and a survival analysis was conducted.

Results

According to above analysis, CCL8, CD80, IDO1 , and CXCL11 were identified as prognostic genes, with low-risk patients demonstrating longer survival times. Additionally, the nomogram proved effective in predicting the survival probability for patients with SKCM. The analysis revealed significant differences in 17 immune cell types between the two cohorts. The pRRophetic analysis generated computationally predicted IC 50 values, with 109 compounds showing between-group differences; these estimates do not represent measured treatment responses.

Conclusion

This study identified four B cell-related prognostic genes ( CCL8, CD80, IDO1 , and CXCL11 ) and developed a prognostic model for SKCM. These findings provide a basis for further investigation of B cell-related prognostic features in SKCM; however, the biological relevance and clinical utility of the model require further experimental and prospective clinical validation.

Zitieren

APA

Wu, J., Maihemuti, M., Yang, W., He, H., & Jiang, R. (2026). Identification and External Transcriptomic Validation of a B Cell-Associated Prognostic Genes in Cutaneous Melanoma. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-21. https://doi.org/10.2147/ccid.s637618

Vancouver

Wu J, Maihemuti M, Yang W, He H, Jiang R. Identification and External Transcriptomic Validation of a B Cell-Associated Prognostic Genes in Cutaneous Melanoma. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-21. doi:10.2147/ccid.s637618

BibTeX
@article{Wu2026,
  author = {Wu, Junshen and Maihemuti, Maierdanjiang and Yang, Wenpeng and He, Haiyang and Jiang, Renbing},
  title = {Identification and External Transcriptomic Validation of a B Cell-Associated Prognostic Genes in Cutaneous Melanoma},
  journal = {Clinical, Cosmetic and Investigational Dermatology},
  year = {2026},
  volume = {Volume 19},
  pages = {1--21},
  doi = {10.2147/ccid.s637618}
}
Kostenlos starten →